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Shwachman-Diamond Syndrome (SDS) is an autosomal recessive disease (#260400) characterized 
by pancreatic exocrine insufficiency, haematological abnormalities (neutropenia and anaemia), 
bone marrow failure (with increased risk for acute myeloid leukaemia (AML) or myelodysplasia 
(MDS) and skeletal alterations. 
As suggested by international guidelines
1
, the SDS clinical diagnosis is confirmed by detection of 
bi-allelic pathogenic variants in SBDS gene, localized at 7q11.21
2,3
. 
Targeted mutation analysis of exon 2 by PCR_RFLP discloses in at least 90% of SDS patients one 
of the three common mutations, (c.185_184TA>CT, c.258+2T>C and the combination of 
c.[183_184TA>CT:258+2T>C] on one allele). Two of the common mutations are observed 
concomitantly in approximately 62% of SDS patients
3
.
  
In our laboratory, starting from 2003, we performed SBDS molecular analysis confirming the 
clinical diagnosis in 115 patients, and all of them harboured at least one of the classical mutations in 
exon 2.  
We recently found two families, each of them with two affected children (UPN 42, UPN 43  and 
UPN 61, UPN 76), carrying only the [c.258+2T>C] mutation; no other DNA changes was found 
after complete sequencing analysis of all five exons and their flanking intronic regions of SBDS.  In 
both families, the clinical picture of the patients completely fits the diagnostic criteria. 
Western-blot analysis using SBDS antibody did not demonstrate any SBDS protein in these 
patients, suggesting the presence of a more complex anomaly on the second allele (Fig. 1). 
We performed a deletion/duplication analysis by long-range gDNA PCR with the specific primers 
designed as Boocock et al.
2
, but matching them differently to obtain longer amplicons  containing 
more exons. When using the following primers [forward for exon 2] and [reverse for exon 4], that 
amplify  the region from exon 2 to exon 4, we observed in both index cases the expected band of 
3756 bp and the presence of a second smaller band of approximately 3000 bp (Fig. 2).  
We then extracted the DNA from the smaller band and used it as template in a new long-range PCR 
experiment, with the same primers as before. Direct sequencing of PCR product demonstrated a 
deletion of exon 3; breakpoints at 5’ and 3’ are located, respectively, in intron 2 and in intron 3.  
The coordinates of the deleted region in GRCh37/hg19 assembly are chr7: g.66457801-66458666, 
with a deletion size of 866 bp. According to nomenclature for sequence variations
4
, we describe the 
mutation as [c.258+533_459+403del]. The presence of the mutation was confirmed in the father of 
UPN 42/43 and in the mother of UPN 61/76. 
The two families we studied are unrelated, the family names of the two parents carrying the deletion 
of exon 3 are uncommon in Italy, and have their higher incidence in different Italian areas, far apart 
from each other, as Sicily and Lazio; available evidence suggest that the mutations arose 
independently in the two families. 
In the 92 index cases known to the Italian registry, mutations other than the common ones are 14, 
only one of them [c.187G>T; p.G63C], damaging according to the prediction tools POLYPHEN 2 
and SYFT, was observed twice  but the two families originate from the same area (Tuscany). 
Therefore, the mutation we report is the second one (different from the common ones) that is 
present twice in the Italian population, in 2 out of 184 pathogenic alleles. 
Costa et al.
5
, described the only case reported so far of a large deletion, paternally inherited, 
removing exon 3; they hypothesized that the deletion derived from an excision event mediated by 
the AluSx elements which are present in introns 2 and 3.  The authors extensively discussed the 
mechanism of origin of the deletion, underlined that there is a 80% of homology between intron 2 
and 3 of the gene, that breakpoints are within AluSx elements, close to a 21 bp tract of completely 
homologous sequence. They conclude that the likely mechanism is “a mispairing of homologous 
sequences and unequal crossing over between introns 2 and 3 of SBDS gene”.   
The deletion observed in our cases overlaps, but not completely, with the one reported by Costa et 
al. 5. We aligned (BLAST sequence analysis tool) full sequences of intron 2 and intron 3 of SBDS 
and SBDSP1 and the sequences of the 21 bp tracts present in both intron 2 and 3.  
We found a high level of homology between intron 2 and intron 3 in SBDS and SBDSP1 (95% for 
intron 2, and 94% for intron 3), while the level of homology for the three 21 bp tracts present in 
both intron 2 and 3 between gene and pseudogene ranged from 95,2% to 98,4%.  
Carvalho et al.
6 
reported an uncommon SDS genotype in a white/Hispanic female: a rare mutation 
[c.98A > C; p.K33T] was associated to a large insertion of an unknown segment near 5’ of intron 1 
or 2 in the SBDS gene. 
When discussing the origin of the insertion, they suggested that it arose from non-homologous 
allelic recombination (NAHR) between SBDS and the closely located SBDSP1 pseudogene. 
This statement was based on the evidence that the SBDSP1 shares 97% identity with SBDS and is in 
an inverted orientation in a closely duplicated genomic segment. Such a structure may result in 
genomic instability and enhance the chance of NAHR and inversion structural variation (SV). 
Significantly, SBDS is one of the 31 disease-associated genes identified intersecting in a genome-
wide analysis the location of the inverted repeats with information for gene localisation on 
chromosomes
7
. Other examples of diseases in which these SV are common include Hunter 
syndrome (IDS gene and its telomeric pseudogene IDSP1) and hemophilia A (factor VIII gene). 
These data are in keeping with the high frequency of gene conversion events in generating the 
common pathogenic alleles found in SDS patients, and in general, the possibility of NAHR 
associated to the presence inverted paralogous-low copy repeats (IP-LCRs), should be considered 
when, for the previously quoted diseases, routine molecular testing does not immediately identify a 
surely pathogenic mutation. 
Thus in the two unrelated families we report, this mechanism is the most likely to generate the 
deletion of exon 3. 
Kuijpers et al.
8
 and Donadieu et al 
9 
report failure to identify pathogenic sequence variations 
respectively in 5/20 and 2/104 case, whose clinical picture seemed well consistent with the 
diagnosis of SDS. 
Therefore, it is now our policy to perform Western blotting analysis and a search for genomic 
rearrangements in all cases in whom a reliable clinical diagnosis is not followed by evidence of 
biallelic mutations. 
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